GSK has halted all shipments of ARIXTRA Starter Kits containing the Triad For important product information, log onto Arixtra mg/ ml solution for injection, pre-filled syringe. 2. .. Detailed information on this medicinal product is available on the website of the European . Arixtra is a medicine that helps prevent blood clots from forming in the blood This medicinal product contains less than 23 mg of sodium in each dose and.
|Published (Last):||7 September 2007|
|PDF File Size:||18.2 Mb|
|ePub File Size:||18.39 Mb|
|Price:||Free* [*Free Regsitration Required]|
A randomized double-blind trial. LMWHs or fondaparinux generally preferred over heparin for initial treatment of acute venous thromboembolism; however, heparin may be preferred in patients with renal impairment.
Arixtra Monograph for Professionals –
ACCP recommends fondaparinux as an option for thromboprophylaxis in acutely ill, hospitalized medical patients at increased risk of thrombosis. Insert the entire length of the needle into a skin fold created by the thumb and forefinger; hold the skin fold, and push the plunger of the syringe the full length of the syringe barrel. Patients undergoing hip-fracture, hip- or knee-replacement surgery: Prevention of VTE in nonsurgical patients: Do not administer earlier than 6—8 hours after surgery because of increased risk of major bleeding.
A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. Food and Drug Administration.
In healthy adults, distributes mainly in blood and only to a minor extent in extravascular fluid. Initiate concurrent warfarin as soon as possible, preescribing usually within 72 hours of fondaparinux injection; 1 20 ACCP recommends initiating warfarin simultaneously on the first day of fondaparinux treatment.
Initial parenteral anticoagulants with established efficacy in patients with NSTE ACS include enoxaparin, heparin, bivalirudin only in patients managed with an early invasive strategyand fondaparinux. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture pdescribing Print this page Add to My Med List. Importance of discontinuing fondaparinux and immediately contacting a clinician if a serious allergic reaction e.
Subscribe to free Drugs. Some packaging components e. Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed. Used in conjunction with warfarin for treatment of DVT and acute PE when initial therapy is administered in the hospital. When selecting an appropriate thromboprophylaxis regimen, consider factors such as relative efficacy, bleeding risk, logistics, and compliance issues. Importance of informing patients that concomitant use of aspirin or other NSAIAs can increase risk of bleeding, and to discontinue use of these drugs whenever possible.
Risk increased by use of indwelling epidural catheters or by concomitant use of drugs affecting hemostasis e. Importance xrixtra advising patients who have had neuraxial anesthesia or spinal puncture to monitor for manifestations of spinal or epidural hematoma e. Discontinue oral anticoagulants prior to initiation of fondaparinux 1 40 If coadministration is essential, monitor patients closely 1 Periodic routine blood lrescribing, including informationn counts, and tests for occult blood in stool recommended.
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: Has been administered at an initial dose of 2. Evaluate the possibility of an underlying bleeding disorder before initiation of treatment. Medically reviewed on Oct 23, Discontinue platelet-aggregation inhibitors prior to initiation of fondaparinux 1 Prevention of postoperative DVT and PE in patients undergoing hip-fracture, hip-replacement, or knee-replacement surgery.
Discontinue NSAIAs prior to initiation of fondaparinux 1 40 If coadministration is essential, monitor patients closely Clin Appl Thromb Hemost.
Subcutaneous fondaparinux versus intravenous unfractionated heparin prescribkng the initial treatment of pulmonary embolism. Optimal timing between administration of fondaparinux and neuraxial procedures not known. Anticoagulation results from rapid inhibition of factor Xa by antithrombin III bound to fondaparinux about fold greater than innate activity. Am J Health-Syst Pharm. Used for extended prophylaxis i.
Constipation, headache, insomnia, fever, nausea, urinary tract infection, coughing. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip- fracture surgery.
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: Binds selectively to antithrombin III; unable to inactivate thrombin.
Bridgewater, NJ; Jul. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. If pharmacologic prophylaxis is indicated in patients undergoing general surgery, ACCP states that an LMWH or low-dose heparin is preferred; fondaparinux may be infofmation when both an LMWH and heparin are contraindicated or not available.
The pharmacokinetics of fondaparinux sodium in healthy volunteers.
The activity of fondaparinux sodium is measured based on plasma drug concentrations quantified by anti-factor Xa activity using fondaparinux as the calibrator. Subscribe to receive email notifications whenever new articles are published. Anticoagulant effects may persist for 2—4 days following discontinuance of therapy in patients with normal renal function i. Extended thromboprophylaxis for up to 35 days is recommended in patients undergoing hip fracture surgery, 40 and suggested for patients undergoing other major orthopedic procedures.
Patients should be sitting or supine during administration. Importance of patients informing clinicians including dentists that they are receiving fondaparinux therapy before scheduling any invasive procedures.